The Drugs Controller General of India (DCGI) has formally announced the final approval for Oxford-AstraZeneca “Covishield” and Bharat Biotech “Covaxin” vaccines against the coronavirus disease (Covid-19) for emergency use. CDSCO (Central Drugs Standard Control Organisation) accepts the subject expert committee reform rations on Serum and Bharat Biotech Covid vaccines.
About Covishield:
The subject expert committee (SEC) under CDSCO had recommended Oxford-AstraZeneca’s vaccine, which is being manufactured by the Serum Institute of India (SII) as Covishield, for emergency use and Covaxin for restricted use.
About Covaxin:
Covaxin is the indigenous vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
Important takeaways for all competitive exams:
Chinese human-like robots have attracted attention following their participation in a 100-meter dash event where…
The Onam festival of 2026 is being celebrated throughout the state of Kerala through colorful…
The US government has unveiled an operation called Economic Outcast, which is a new global…
The National Security Guard (NSG) has inaugurated the first-ever Mahila Commando Conversion Course (MCCC) at…
National Conclave on Tribal Languages and Museums was launched in the Mysuru, Karnataka, on August…
As per a recent report released by NITI Aayog, close to 8.7 crore Indians between…